Qepler | summits & conferences | 4th Annual Pharmaceutical Lyophilization Hybrid Summit, 6-7 October 2022, Prague, Czech Republic
Event Location:
Prague, Czech Republic
06 October 2022 - 07 October 2022
Contact Person: Evgenia Makar
Contact Person: Evgenia Makar, Qepler s.r.o.
Contact Person: Denis Polikarpov
Contact Person: Denis Polikarpov, Qepler s.r.o.

Conference Overview

Although lyophilization is an old process, it remains to be complex. Today we can see increased trend in aseptic freeze-dried products, including biologics, APIs, nanomaterials and new devices. It makes the lyophilization cycle more complicated. Lyophilization becomes systematic and scientific process.

Pharmaceutical Lyophilization Summit 2022 is a knowledge sharing to showcase best practices in technical and regulatory updates, manufacturing and process development, freeze-dried formulation, testing, monitoring and new products development.

The featured talks on:

  • We need bigger crystals quo vadis controlled nucleation?
  • GMP-ready continuous freeze-drying of pharmaceuticals.
  • Freeze drying process design using a Design Space approach.
  • The influence of formulation in freeze drying biologics
  • Anatomy of the Lyophilization Process: Considerations for a Successful Tech Transfer.
  • Alternative Freeze Drying Technologies and Options for Process Intensification
  • Where’s the true sublimation end point in primary drying?
  • Impact of Elastomeric Closures on Freeze-dried Cakes.
  • How different vial concepts can help to avoid breakage due to freezing.
  • 4040/40 Elastomer Formulation Innovation for Lyo Application.

Meet our Speakers

Our Partners

Bronze Sponsor
Absolute freedom in product temperature measurement in lyophilization and sterilisation with Tempris wireless, real-time and battery free sensors.
Tempris GmbH



Applied Materials, Inc., USA - Aspen, ZA - Azbil Telstar Technologies SLU, ES - Baxter Healthcare, USA - Bayer AG, DE - Biopharma Group, UK - Boehringer Ingelheim, DE - Cambridge Design Partnership, UK - Catalent Biologics, USA - Catalent Pharma LLC, USA - Catalent Pharma Solutions , UK - Cenexi Lt sa, BE - Daiichi-Sankyo Europe GmbH, DE -Datwyler Pharma Packaging International NV, BE - De Montfort University, UK - Dr. Reddy's lab, IN - ELLAB A/S, DK - eTheRNA Immunotherapies NV, BE - Explicat Pharma GmbH, DE - Ferring GmbH, DE - Fresenius Kabi Oncology Ltd., IN - GEA Lyophil GmbH, DE - GSK, USA - Hemofarm, RS - Illumina, UK - Janssen, BE - Jazz Pharmaceuticals, CA - Laboratorio Reig Jofre, S.A., ES - LMU Munich, Pharmaceutical Technology and Biopharmacy, DE - Lyofal, FR - Lyomark Pharma GmbH, DE - Medichem Manufacturing (Malta) Limited, MT - Merck, USA - Merck KGaA, DE - Minapharm for pharmaceutical products, EG - NIBSC, UK - OPTIMA pharma GmbH, DE - Pfizer, BE - PharmaMar SA, ES - RAUMEDIC AG, DE - Sanofi-Aventis, FR - Sirton Pharmaceuticals SpA, IT - Takeda, AT - Tempris GmbH, DE - Terumo BCT, USA - University of Helsinki, FI - West Pharmaceutical Services, USA - World Health Organization, CH - Yuria-Pharm LLC, UA - and others.


Bram Jongen

Datwyler Pharma Packaging International NV

chaired a panel discussion with speakers from Shire, MSD, Bayer, Martin Christ, Boehringer Ingelheim, Ghent University, Lonza and De Montfort University.